.Pharmacolibrary.Drugs.V_Various.V09I_TumourDetection.V09IX09_Gallium68gaEdotreotide.Gallium68gaEdotreotide .Pharmacolibrary.Drugs.V_Various.V09I_TumourDetection.V09IX09_Gallium68gaEdotreotide.Gallium68gaEdotreotide| name: | Gallium68gaEdotreotide |
| ATC code: | V09IX09 | route: | intravenous |
| n-compartments | 2 |
Gallium (68Ga) edotreotide is a radiolabeled somatostatin analog used as a diagnostic imaging agent in positron emission tomography (PET) for the localization of somatostatin receptor-positive neuroendocrine tumors. It is not a therapeutic drug, but a diagnostic agent. The agent is currently in clinical use for neuroendocrine tumor imaging.
Estimated pharmacokinetic parameters for adult human subjects based on typical PET radiotracer characteristics and published data on closely related radiolabeled somatostatin analogues; no direct PK studies for (68Ga) edotreotide are available.